IL6 and breast carcinoma: Inhibition of IL-6 signalling pathway through neutralising IL-6 antibody and siRNA found both breast cancer cell lines exhibited decreased migratory and invasive potential with reduced SNAI1 transcription (Gyamfi et al., 2018).